Bromantane and antibody-producing cells in mice
T. S. Galushina, T. A. Fadeeva, N. G. Artsimovich · 1996 · Immunologiya. 1996;(4):31–34.
Reported findings and study design
Narrative findings; numerical extraction incomplete
In vivo mouse experiments. The abstract reports injected doses of 10–200 mg/kg in antigen-response experiments and describes separate induced immune-deficit models.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Antibody-producing B cells | Increased number and functional activity | CBA and C57BL/6J mice |
| IgM production | Increased | Induced immune-deficit mouse models |
Source for these results ↗ · Reviewed 2026-11-10
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The abstract gives a dose range but no arm sizes, effect sizes or individual dose results.
- Overlap with experiments disclosed by the same group in RU1826906C is unresolved.
Source access
Original article abstract available. Full methods and numerical tables require the complete article.
Source reviewed 2026-11-10.
Citation and original source
Original source: T. S. Galushina, T. A. Fadeeva, N. G. Artsimovich. Bromantane and antibody-producing cells in mice Immunologiya. 1996;(4):31–34. 1996.
Molekul research summary: https://molekul.io/research/bromantane-galushina-humoral-immunity-1996. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry